ALB and chronic kidney disease: However, inadequate quality indicator metrics performance was concerned within the domains of processes of care and testing (i.e., annual eye examination and urine dipstick test and/or UACR measurement at least once yearly) and medication use and disease control [i.e., HbA1c <8.0%, systolic and diastolic BP <140/90 mmHg, use of statin therapy based on recommended guidelines, and use of ACEI/ARBs therapy for persons with CKD or urine albumin excretion >30 mg/24 h (or equivalent)].